McKesson Corporation (LON:0JZU)
782.10
-1.00 (-0.13%)
At close: Oct 15, 2025
McKesson Revenue
McKesson had revenue of $97.83B USD in the quarter ending June 30, 2025, with 23.39% growth. This brings the company's revenue in the last twelve months to $377.60B, up 20.35% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$377.60B
Revenue Growth
+20.35%
P/S Ratio
0.27
Revenue / Employee
$8.39M
Employees
45,000
Market Cap
73.53B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
McKesson News
- 5 days ago - McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity - Seeking Alpha
- 5 days ago - Here's How Much You Would Have Made Owning McKesson Stock In The Last 10 Years - Benzinga
- 6 days ago - Guru Fundamental Report for MCK - Nasdaq
- 7 days ago - McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio - Nasdaq
- 9 days ago - Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report? - Nasdaq
- 13 days ago - McKesson (MCK) Achieves High Rating Amidst Healthcare Sector Fluctuations - GuruFocus
- 15 days ago - See How McKesson Shares Rise with Money Flows - FX Empire
- 19 days ago - Noteworthy ETF Outflows: USMV, MCK, MSI, RSG - Nasdaq